Fair Isaac Total Cost of Revenue increased by 4.5% to $91.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.1%, from $87.63M to $91.20M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 1.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.24M | $72.36M | $69.20M | $71.79M | $78.69M | $82.49M | $76.57M | $79.81M | $71.85M | $82.83M | $83.46M | $86.95M | $88.23M | $89.57M | $87.35M | $87.63M | $87.57M | $91.18M | $87.26M | $91.20M |
| QoQ Change | — | -12.0% | -4.4% | +3.7% | +9.6% | +4.8% | -7.2% | +4.2% | -10.0% | +15.3% | +0.8% | +4.2% | +1.5% | +1.5% | -2.5% | +0.3% | -0.1% | +4.1% | -4.3% | +4.5% |
| YoY Change | — | — | — | — | -4.3% | +14.0% | +10.6% | +11.2% | -8.7% | +0.4% | +9.0% | +8.9% | +22.8% | +8.1% | +4.7% | +0.8% | -0.7% | +1.8% | -0.1% | +4.1% |